The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(Cyclopropylmethoxy)-N-(1-(5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl)-2-methylpropan-2-yl)-5-(3-methoxyazetidin-1-yl)-picolinamide ID: ALA3582015
PubChem CID: 118418641
Max Phase: Preclinical
Molecular Formula: C26H30FN5O4
Molecular Weight: 495.56
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COC1CN(c2ccc(C(=O)NC(C)(C)Cc3nnc(-c4ccc(F)cc4)o3)nc2OCC2CC2)C1
Standard InChI: InChI=1S/C26H30FN5O4/c1-26(2,12-22-30-31-24(36-22)17-6-8-18(27)9-7-17)29-23(33)20-10-11-21(32-13-19(14-32)34-3)25(28-20)35-15-16-4-5-16/h6-11,16,19H,4-5,12-15H2,1-3H3,(H,29,33)
Standard InChI Key: JXVJDIAWUVGLSZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 40 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5642 -5.0103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3142 -3.7112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5987 1.5004 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0035 1.0886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3894 2.5381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9399 2.9240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6812 3.2902 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6775 4.4902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5972 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6375 -0.9049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5951 -3.0039 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8912 -5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8956 -2.5570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9336 -3.1588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1894 -6.0109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3272 -7.4918 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.7944 -7.8036 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.5445 -6.5046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5408 -5.3899 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-9.0370 -6.3478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.0036 -7.4883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.4793 -7.2197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.9846 -5.8074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.0141 -4.6636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.5384 -4.9322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-13.1652 -5.5925 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 1 0
8 9 1 0
10 9 1 0
11 10 1 0
9 11 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 12 1 0
2 12 1 0
16 17 1 0
14 16 1 0
5 18 1 0
18 19 2 0
18 20 1 0
20 21 1 0
21 22 1 0
21 23 1 0
21 24 1 0
22 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 25 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 30 1 0
28 30 1 0
33 36 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 495.56Molecular Weight (Monoisotopic): 495.2282AlogP: 3.65#Rotatable Bonds: 10Polar Surface Area: 102.61Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 0.24CX LogP: 3.26CX LogD: 3.26Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.45Np Likeness Score: -1.41
References 1. Slavik R, Grether U, Müller Herde A, Gobbi L, Fingerle J, Ullmer C, Krämer SD, Schibli R, Mu L, Ametamey SM.. (2015) Discovery of a high affinity and selective pyridine analog as a potential positron emission tomography imaging agent for cannabinoid type 2 receptor., 58 (10): [PMID:25950914 ] [10.1021/acs.jmedchem.5b00283 ]